Stay updated on TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial

Sign up to get notified when there's something new on the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The site footer now identifies revision v3.8.0 instead of v3.7.2, while the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:49:55.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    A notice appears above the page announcing NIH website transition updates and explaining that “Super Intelligence” is being used in place of “Artificial Intelligence” during the transition.
    Difference
    1%
    Check dated 2026-10-24T13:11:41.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.1 to v3.7.2 on the error page.
    Difference
    0.2%
    Check dated 2026-10-17T13:19:09.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer now identifies the site revision as v3.7.1 instead of v3.7.0. The page content remains a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T14:10:45.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the study record content with a standard error page.
    Difference
    19%
    Check dated 2026-09-19T20:10:07.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing v3.6.5, indicating a minor update to the page's revision history; the updated revision does not change the study details presented.
    Difference
    0.1%
    Check dated 2026-08-29T20:00:29.000Z thumbnail image

Stay in the know with updates to TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the TG4010, Nivolumab & Chemotherapy in NSCLC Clinical Trial page.